{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:35:55Z","timestamp":1792787755434,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.ophtha.2010.02.021","type":"journal-article","created":{"date-parts":[[2010,4,16]],"date-time":"2010-04-16T04:44:40Z","timestamp":1271393080000},"page":"1102-1112.e1","source":"Crossref","is-referenced-by-count":727,"title":["Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion"],"prefix":"10.1016","volume":"117","clinical-trial-number":[{"clinical-trial-number":"nct00486018","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Peter A.","family":"Campochiaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Heier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard","family":"Feiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Saroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Chen","family":"Rundle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Yee","family":"Murahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman G.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2010.02.021_bib1","first-page":"561","article-title":"Retinopathy in a population-based study","volume":"90","author":"Klein","year":"1992","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2010.02.021_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007324.pub2","article-title":"Intravitreal steroids versus observation for macular edema secondary to central retinal vein occlusion","volume":"1","author":"Gewaily","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ophtha.2010.02.021_bib3","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archopht.126.4.513","article-title":"The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study","volume":"126","author":"Klein","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.02.021_bib5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/archopht.1982.01030040110020","article-title":"Histopathologic study of nine branch retinal vein occlusions","volume":"100","author":"Frangieh","year":"1982","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.02.021_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0002-9394(84)90316-7","article-title":"Argon laser photocoagulation for macular edema in branch vein occlusion","volume":"98","year":"1984","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.02.021_bib7","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","volume":"331","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2010.02.021_bib8","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/mt.2008.10","article-title":"Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator","volume":"16","author":"Campochiaro","year":"2008","journal-title":"Mol Ther"},{"key":"10.1016\/j.ophtha.2010.02.021_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ajo.2005.03.003","article-title":"Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6","volume":"140","author":"Noma","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.02.021_bib10","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1006\/exer.1996.0239","article-title":"Intravitreal sustained release of VEGF causes retinal neovascularization in rabbits and breakdown of the blood-retinal barrier in rabbits and primates","volume":"64","author":"Ozaki","year":"1997","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.ophtha.2010.02.021_bib11","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2010.02.021_bib12","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2010.02.021_bib13","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.02.021_bib14","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/sim.4780122410","article-title":"Dynamic balanced randomization for clinical trials","volume":"12","author":"Signorini","year":"1993","journal-title":"Stat Med"},{"key":"10.1016\/j.ophtha.2010.02.021_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archopht.124.2.193","article-title":"Normal macular thickness measurements in healthy eyes using Stratus optical coherence tomography","volume":"124","author":"Chan","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2010.02.021_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"Collaborative overview of randomized trials of antiplatelet therapy\u2014I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2010.02.021_bib17","series-title":"Lucentis","year":"2007"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010001855?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642010001855?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T17:22:38Z","timestamp":1544548958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642010001855"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S0161642010001855"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2010.02.021","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.10125956.10898054","asserted-by":"object"}]},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}